FACILITATE was a real-world, prospective, multicenter European study that evaluated performance and aTAT of the IdyllaTM EGFR Mutation Test compared with local reference methods in real-life NSCLC settings. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.